Skip Navigation LinksHome > January 2002 - Volume 15 - Issue 1 > Maintenance treatment in depression: the role of pharmacolog...
Current Opinion in Psychiatry:
Mood Disorders

Maintenance treatment in depression: the role of pharmacological and psychological treatment

Winkler, Dietmar; Tauscher, Johannes; Kasper, Siegfried

Collapse Box


There is increased recognition and acceptance that the majority of depressive disorders can be viewed as chronic or recurrent medical illnesses, which lead to persistent human suffering, severe psychosocial disability, and increased mortality, thus presenting highly expensive conditions in primary care. Results of controlled clinical trials indicate that patients should receive 4-6 months of continuation therapy after remission of the acute phase of the illness. Patients at risk for recurrent episodes, however, should receive a maintenance pharmacotherapy since depressive disorder appears to become more severe and potentially refractory with each new episode. This review summarizes recent research and provides guidelines for long-term treatment of depressive disorders.

© 2002 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics